Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Isabella Damiani, Alberto Corsini & Stefano Bellosta. (2020) Potential statin drug interactions in elderly patients: a review. Expert Opinion on Drug Metabolism & Toxicology 16:12, pages 1133-1145.
Read now
Read now
Claudio Ponticelli, Lorenzo Arnaboldi, Gabriella Moroni & Alberto Corsini. (2020) Treatment of dyslipidemia in kidney transplantation. Expert Opinion on Drug Safety 19:3, pages 257-267.
Read now
Read now
Venkata Nookaapparao Gorli & Rajagopal Srinivasan. (2020) Synthesis of spirooxindole analogues from 2-cyclopropyl-4-(4-fluorophenyl)quinoline-3-carbaldehyde. Synthetic Communications 50:4, pages 516-525.
Read now
Read now
Maria del Mar Gutierrez, Mª Gracia Mateo, Noemí Corbacho, Francesc Vidal & Pere Domingo. (2019) Drug-drug interactions when treating HIV-related metabolic disorders. Expert Opinion on Drug Metabolism & Toxicology 15:10, pages 787-802.
Read now
Read now
Paul Chan, Li Shao, Brian Tomlinson, Yuzhen Zhang & Zhong-Min Liu. (2019) An evaluation of pitavastatin for the treatment of hypercholesterolemia. Expert Opinion on Pharmacotherapy 20:1, pages 103-113.
Read now
Read now
Stefano Bellosta & Alberto Corsini. (2018) Statin drug interactions and related adverse reactions: an update. Expert Opinion on Drug Safety 17:1, pages 25-37.
Read now
Read now
Ning Ma & Lianqun Cui. (2015) Comparative efficacy of pitavastatin and simvastatin in patients with hypercholesterolemia: a meta-analysis of randomized controlled clinical trials. Drug Design, Development and Therapy 9, pages 1859-1864.
Read now
Read now
Miao Hu & Brian Tomlinson. (2014) Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin. Expert Opinion on Drug Metabolism & Toxicology 10:1, pages 51-65.
Read now
Read now
Yasushi Kono, Shota Fukuda, Kenei Shimada, Koki Nakanishi, Kenichiro Otsuka, Tomoichiro Kubo, Satoshi Jissho, Haruyuki Taguchi, Junichi Yoshikawa & Minoru Yoshiyama. (2013) Very rapid effect of pitavastatin on microvascular function in comparison to rosuvastatin: reactive hyperemia peripheral arterial tonometric study. Drug Design, Development and Therapy 7, pages 369-374.
Read now
Read now
Vivencio Barrios, Carlos Escobar & José L Zamorano. (2013) Searching the place of pitavastatin in the current treatment of patients with dyslipidemia. Expert Review of Cardiovascular Therapy 11:12, pages 1597-1612.
Read now
Read now
Shilpa Bhardwaj, Shalini Selvarajah & Eric B Schneider. (2013) Muscular effects of statins in the elderly female: a review. Clinical Interventions in Aging 8, pages 47-59.
Read now
Read now
Stefano Bellosta & Alberto Corsini. (2012) Statin drug interactions and related adverse reactions. Expert Opinion on Drug Safety 11:6, pages 933-946.
Read now
Read now
Claudio Borghi & Arrigo Fg Cicero. (2012) Which statin is the ideal statin for polymedicated patients?. Clinical Lipidology 7:sup1, pages 11-16.
Read now
Read now
Alberico L Catapano. (2012) Pitavastatin: a different pharmacological profile. Clinical Lipidology 7:sup1, pages 3-9.
Read now
Read now
Articles from other publishers (35)
Craig Thomas, Henry Ellison & George E. Taffet. (2023) Deprescribing statins, considerations for informed decision making. Journal of the American Geriatrics Society 71:8, pages 2685-2689.
Crossref
Crossref
Sunjae Bae, JiYoon B. Ahn, Corey Joseph, Ryan Whisler, Mark A. Schnitzler, Krista L. Lentine, Bernard S. Kadosh, Dorry L. Segev & Mara A. McAdams-DeMarco. (2023) Incidence of Statin-Associated Adverse Events in Kidney Transplant Recipients. Clinical Journal of the American Society of Nephrology 18:5, pages 626-633.
Crossref
Crossref
Joanna Bojarska, Martin Breza, Milan Remko, Paweł Borowiecki, Andrzej Fruziński, Izabela D. Madura, Krzysztof Kaczmarek, Zbigniew Leśnikowski, Agata Kraj, Piotr Zielenkiewicz & Wojciech M. Wolf. (2022) Supramolecular synthon hierarchy in cyclopropyl-containing peptide-derived compounds. CrystEngComm 24:48, pages 8372-8389.
Crossref
Crossref
Soumik De, Aritra Kumar Dan, Raghaba Sahu & Debadutta Das. (2022) Asymmetric Synthesis of Halocyclized Products by Using Various Catalysts: A State‐of‐the‐Art Review. European Journal of Organic Chemistry 2022:32.
Crossref
Crossref
Marina G. Bubnova. (2022) Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review. CardioSomatics 13:1, pages 31-42.
Crossref
Crossref
Cesare R Sirtori, Shizuya Yamashita, Maria Francesca Greco, Alberto Corsini, Gerald F Watts & Massimiliano Ruscica. (2019) Recent advances in synthetic pharmacotherapies for dyslipidaemias. European Journal of Preventive Cardiology 27:15, pages 1576-1596.
Crossref
Crossref
Yongin Cho, Hyangkyu Lee, Hyun Ki Park, Eun Yeong Choe, Hye Jin Wang, Ryeong-Hyeon Kim, Youjin Kim & Eun Seok Kang. (2020) Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, <i>in vitro</i> and <i>in vivo </i>. Journal of Atherosclerosis and Thrombosis 27:5, pages 429-440.
Crossref
Crossref
Han Saem Jeong, Soon Jun Hong, Serhim Son, Hyonggin An, Hyungdon Kook, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu & Do-Sun Lim. (2019) Incidence of new-onset diabetes with 1 mg versus 4 mg pitavastatin in patients at high risk of developing diabetes during a 3-year follow-up. Cardiovascular Diabetology 18:1.
Crossref
Crossref
Julia Bird, Philip Calder & Manfred Eggersdorfer. (2018) The Role of n-3 Long Chain Polyunsaturated Fatty Acids in Cardiovascular Disease Prevention, and Interactions with Statins. Nutrients 10:6, pages 775.
Crossref
Crossref
Leigh Anne Hylton Gravatt, Rachel W. Flurie, Estela Lajthia & Dave L. Dixon. (2017) Clinical Guidance for Managing Statin and Antimicrobial Drug-Drug Interactions. Current Atherosclerosis Reports 19:11.
Crossref
Crossref
Jens Barthelmes & Isabella Sudano. (2017) Medikamentöse Senkung des LDL-Cholesterins. Praxis 106:17, pages 933-940.
Crossref
Crossref
Sheridan M. Hoy. (2017) Pitavastatin: A Review in Hypercholesterolemia. American Journal of Cardiovascular Drugs 17:2, pages 157-168.
Crossref
Crossref
Nicola Ferrara, Graziamaria Corbi, Klara Komici & Giuseppe Rengo. 2017. Cardiac Management in the Frail Elderly Patient and the Oldest Old. Cardiac Management in the Frail Elderly Patient and the Oldest Old
63
70
.
Vivencio Barrios & Carlos Escobar. (2016) Clinical benefits of pitavastatin: focus on patients with diabetes or at risk of developing diabetes. Future Cardiology 12:4, pages 449-466.
Crossref
Crossref
Michele Thai, Emily Reeve, Sarah N Hilmer, Katie Qi, Sallie-Anne Pearson & Danijela Gnjidic. (2016) Prevalence of statin-drug interactions in older people: a systematic review. European Journal of Clinical Pharmacology 72:5, pages 513-521.
Crossref
Crossref
Annett Kunze, Birk Poller, Jörg Huwyler & Gian Camenisch. (2015) Application of the extended clearance concept classification system (ECCCS) to predict the victim drug-drug interaction potential of statins. Drug Metabolism and Personalized Therapy 30:3, pages 175-188.
Crossref
Crossref
Weiqi Chen, Fangjun Xiong, Qian Liu, Lingjun Xu, Yan Wu & Fener Chen. (2015) Substrate stereocontrol in bromine-induced intermolecular cyclization: asymmetric synthesis of pitavastatin calcium. Tetrahedron 71:29, pages 4730-4737.
Crossref
Crossref
Natalia Mora Cuadrado. (2015) Pitavastatin: Other statin to be used and monitored. Revista Española de Enfermedades Digestivas.
Crossref
Crossref
Lorenzo Arnaboldi & Alberto Corsini. (2015) Could changes in adiponectin drive the effect of statins on the risk of new-onset diabetes? The case of pitavastatin. Atherosclerosis Supplements 16, pages 1-27.
Crossref
Crossref
Yufan Wu, Boleslaw Lach, John P. Provias, Mark A. Tarnopolsky & Steven K. Baker. (2014) Statin-associated Autoimmune Myopathies: A Pathophysiologic Spectrum. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 41:5, pages 638-647.
Crossref
Crossref
Craig A. Sponseller, Roger E. Morgan, Vladimir A. Kryzhanovski, Stuart E. Campbell & Michael H. Davidson. (2014) Comparison of the Lipid-Lowering Effects of Pitavastatin 4 mg Versus Pravastatin 40 mg in Adults With Primary Hyperlipidemia or Mixed (Combined) Dyslipidemia: A Phase IV, Prospective, US, Multicenter, Randomized, Double-blind, Superiority Trial. Clinical Therapeutics 36:8, pages 1211-1222.
Crossref
Crossref
Montserrat Cofan Pujol. (2014) Mecanismos básicos. Absorción y excreción de colesterol y otros esteroles. Clínica e Investigación en Arteriosclerosis 26:1, pages 41-47.
Crossref
Crossref
Hirokazu Kakuda, Junji Kobayashi, Mio Nakato & Noboru Takekoshi. (2013) Short-Term Effect of Pitavastatin Treatment on Glucose and Lipid Metabolism and Oxidative Stress in Fasting and Postprandial State Using a Test Meal in Japanese Men. Cholesterol 2013, pages 1-7.
Crossref
Crossref
A. S. Trenin. (2013) Microbial metabolites inhibiting sterol biosynthesis: Their chemical diversity and characteristics of the mechanism of action. Russian Journal of Bioorganic Chemistry 39:6, pages 565-587.
Crossref
Crossref
Venkata M. Alla, Vrinda Agrawal, Andrew DeNazareth, Syed Mohiuddin, Sudha Ravilla & Marc Rendell. (2013) A Reappraisal of the Risks and Benefits of Treating to Target with Cholesterol Lowering Drugs. Drugs 73:10, pages 1025-1054.
Crossref
Crossref
Matthias Hoch, Petra Hoever, Rudolf Theodor & Jasper Dingemanse. (2013) Almorexant effects on CYP3A4 activity studied by its simultaneous and time-separated administration with simvastatin and atorvastatin. European Journal of Clinical Pharmacology 69:6, pages 1235-1245.
Crossref
Crossref
Jonas G. Barlind, Linda K. Buckett, Sharon G. Crosby, Öjvind Davidsson, Hans Emtenäs, Anne Ertan, Ulrik Jurva, Malin Lemurell, Pablo Morentin Gutierrez, Karolina Nilsson, Gavin O’Mahony, Annika U. Petersson, Alma Redzic, Fredrik Wågberg & Zhong-Qing Yuan. (2013) Identification and design of a novel series of MGAT2 inhibitors. Bioorganic & Medicinal Chemistry Letters 23:9, pages 2721-2726.
Crossref
Crossref
Alberto Corsini & Michele Bortolini. (2013) Drug‐Induced Liver Injury: The Role of Drug Metabolism and Transport. The Journal of Clinical Pharmacology 53:5, pages 463-474.
Crossref
Crossref
최선, 이수경, 나현오, 박은하, 한옥연 & 황유경. (2013) Drug Use Evaluation of Statins Focused on Drug-Drug Interactions. Journal of Korean Society of Health-System Pharmacists 30:2, pages 95-107.
Crossref
Crossref
Mariëtte Y.M. van der Wulp, Henkjan J. Verkade & Albert K. Groen. (2013) Regulation of cholesterol homeostasis. Molecular and Cellular Endocrinology 368:1-2, pages 1-16.
Crossref
Crossref
Miao Hu, Bernard M.Y. Cheung & Brian Tomlinson. (2012) Safety of statins: an update. Therapeutic Advances in Drug Safety 3:3, pages 133-144.
Crossref
Crossref
Kirsty J. McLeanMarcus Hans & Andrew W. Munro. (2012) Cholesterol, an essential molecule: diverse roles involving cytochrome P450 enzymes. Biochemical Society Transactions 40:3, pages 587-593.
Crossref
Crossref
Sivakumar Sathasivam. (2012) Statin induced myotoxicity. European Journal of Internal Medicine 23:4, pages 317-324.
Crossref
Crossref
Jean Davignon. (2012) Pleiotropic effects of pitavastatin. British Journal of Clinical Pharmacology 73:4, pages 518-535.
Crossref
Crossref
Sean T. Duggan. (2012) Pitavastatin. Drugs 72:4, pages 565-584.
Crossref
Crossref